AbbVie has agreed to buy Apogee Therapeutics for about $10.9 billion in cash in a deal that bolsters the biopharmaceutical company’s immunology and inflammation portfolio.
Source link
AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash
Date:
More like thisRelated
Chevron Strikes Power Deal With Microsoft for West Texas AI Data Center
The 2.7-gigawatt project will have its own on-site power...
U.S.-Iran talks set ‘good foundation’ for deal to end war, Vance says
High-level talks between Iran and the United States resulted...
Vance says talks in Switzerland with Iran set ‘good foundation’
Vice President JD Vance said Monday peace talks with...